This is a combination medicine containing imipenem and cilastatin. It's used to treat serious bacterial infections. Cilastatin helps imipenem stay in your body longer and work better by stopping the body from breaking it down in the kidneys.
Every report comes from a Lived member, sent anonymously.
Have you tried Imipenem and Cilastatin for Nontuberculous Mycobacterium Infections?
Imipenem and cilastatin, sold under the brand name Primaxin and as generic versions, is an intravenous antibiotic used for serious bacterial infections, usually in the hospital. It is approved for infections of the lungs, urinary tract, abdomen, female reproductive organs, bones and joints, and skin, as well as bloodstream infections (septicemia) and a heart valve infection (endocarditis) caused by Staphylococcus aureus. It works against a wide range of bacteria, including many that resist simpler antibiotics. Because it covers so many bacteria, it is meant only for infections that are proven or strongly suspected to be bacterial. Using broad antibiotics when they are not needed encourages resistant bacteria. When lab results identify the bacteria and which drugs work against them, the care team may switch to a narrower antibiotic. It is not approved for meningitis (infection of the lining of the brain and spinal cord), and it is not recommended for children with brain or spinal cord infections because of the risk of seizures. A related product, Recarbrio, adds a third ingredient, relebactam, which protects imipenem from enzymes some resistant bacteria use to destroy antibiotics. Recarbrio has its own, narrower uses, such as hospital-acquired pneumonia, and is not interchangeable with Primaxin.
Imipenem belongs to the carbapenem family, a group of antibiotics related to penicillin. It kills bacteria by blocking the enzymes they use to build their cell walls, so the bacteria break apart as they try to grow. On its own, imipenem is quickly broken down by an enzyme in the kidneys, which would lower its levels in the blood and leave little active drug in the urine. Cilastatin has no antibacterial effect of its own. Its job is to block that kidney enzyme, so imipenem stays active long enough to work, including against urinary tract infections. That is why the two are always given together.
Imipenem and cilastatin is given into a vein through an IV line, usually by a nurse in the hospital. For adults with normal kidney function, a typical schedule is a dose every 6 or 8 hours, with each infusion running for about 20 to 60 minutes depending on the dose. The dose listed on the prescription refers to the imipenem portion; an equal amount of cilastatin is in the same bag. Children receive doses based on weight and age. The kidneys clear the drug from the body, so the dose is lowered when kidney function is reduced. Having kidney disease does not by itself rule the medicine out, but people with very low kidney function generally should receive it only if they are on dialysis or will start dialysis soon. Blood tests of kidney function help set the dose. If nausea develops during an infusion, the nurse can slow the drip.
The most common problems are irritation or pain in the vein where the IV runs, nausea, vomiting, diarrhea, rash and fever. Low blood pressure and dizziness can also occur. Most of these are mild, and slowing the infusion often helps with nausea. The most important serious side effect is on the brain. Seizures, muscle twitching or jerking, and confusion have been reported, most often in people who already have a seizure disorder or brain condition, people with reduced kidney function, and when doses are higher than recommended. They can also happen in people with none of these risks. Tell the nurse or doctor right away about any twitching, unusual confusion or a seizure, since the dose may need to be lowered or the antibiotic changed. Allergic reactions, including rare severe ones, can occur. Hives, swelling of the face or lips, or trouble breathing during or after an infusion should be reported to staff immediately so they can stop the drug. Like other antibiotics, it can lead to infection of the colon with Clostridioides difficile (C. diff), which causes diarrhea that ranges from mild to severe. This can begin during treatment or as long as two months afterward. Frequent watery or bloody diarrhea, especially with fever or stomach cramps, should prompt a call to the care team right away, even after leaving the hospital.
Anyone allergic to penicillin, cephalosporins or a carbapenem antibiotic should make sure the care team knows, and should describe what the reaction was. These antibiotics are chemically related, and some people with a penicillin allergy have had severe reactions to drugs in this family. A previous reaction to imipenem or cilastatin means the drug should not be used. The most consequential interaction is with valproic acid or divalproex (Depakote), seizure and mood-stabilizing medicines. Imipenem can lower valproic acid levels below the range that controls seizures, and raising the valproic acid dose may not be enough to correct it, so breakthrough seizures can occur. A different antibiotic is generally preferred for people whose seizures are controlled on valproic acid. Ganciclovir, an antiviral medicine used against cytomegalovirus (CMV) in people with weakened immune systems, has been linked to seizures when given with imipenem and cilastatin, so the two are combined only when the benefit clearly outweighs the risk. Probenecid, a gout medicine also used to raise the levels of some penicillins, raises imipenem levels and is not recommended alongside it. People with a seizure disorder should keep taking their usual seizure medicine during treatment. Limited human data have not identified a clear risk in pregnancy, but information is sparse, and an increase in pregnancy loss was seen in one monkey study. Little is known about passage into breast milk. A doctor can weigh the need for this antibiotic against these unknowns.
Imipenem and cilastatin is often started before the exact bacteria are known, because serious infections cannot wait for lab results. Once lab cultures identify the bacteria and which antibiotics work against them, the team may continue it or switch to a narrower antibiotic, sometimes one taken by mouth. How long treatment lasts depends on the type and site of the infection and on how the person responds; infections of bone or heart valves generally need longer courses than many other infections. During treatment, the team watches kidney function and adjusts the dose if it changes, and with longer courses also checks liver function and blood counts. Because it is given several times a day by IV, it is usually given in a hospital, though some people finish antibiotic courses with home infusion or another drug. Diarrhea in the weeks after finishing is worth taking seriously because of the delayed risk of C. diff.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Imipenem and Cilastatin, what you've noticed, or ask the community a question.